NCT06084884 2026-03-09
ATHENA
AstraZeneca
Phase 1/2 Active not recruiting
Clinical Trials
5 trialsNCT06096038 2026-02-20
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT01089387 2025-12-04
INSTIN
Institut National de la Santé Et de la Recherche Médicale, France
Phase 1/2 Completed
NCT01947322 2017-08-29
NK
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Completed
NCT01337544 2013-11-11
NK
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Phase 1/2 Terminated